Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 984

1.

Lung function testing in the elderly--can we still use FEV1/FVC<70% as a criterion of COPD?

Medbø A, Melbye H.

Respir Med. 2007 Jun;101(6):1097-105. Epub 2007 Jan 18.

2.
3.

Prevalence of chronic obstructive pulmonary diseases in general clinics in terms of FEV1/FVC.

Fukahori S, Matsuse H, Takamura N, Hirose H, Tsuchida T, Kawano T, Fukushima C, Mizuta Y, Kohno S.

Int J Clin Pract. 2009 Feb;63(2):269-74. doi: 10.1111/j.1742-1241.2008.01873.x.

PMID:
19196365
4.

The prevalence of chronic obstructive pulmonary disease in Maastricht, the Netherlands.

Vanfleteren LE, Franssen FM, Wesseling G, Wouters EF.

Respir Med. 2012 Jun;106(6):871-4. doi: 10.1016/j.rmed.2012.01.008. Epub 2012 Feb 19.

5.

Using the lower limit of normal for the FEV1/FVC ratio reduces the misclassification of airway obstruction.

Swanney MP, Ruppel G, Enright PL, Pedersen OF, Crapo RO, Miller MR, Jensen RL, Falaschetti E, Schouten JP, Hankinson JL, Stocks J, Quanjer PH.

Thorax. 2008 Dec;63(12):1046-51. doi: 10.1136/thx.2008.098483. Epub 2008 Sep 11.

PMID:
18786983
6.

Not 15 but 50% of smokers develop COPD?--Report from the Obstructive Lung Disease in Northern Sweden Studies.

Lundbäck B, Lindberg A, Lindström M, Rönmark E, Jonsson AC, Jönsson E, Larsson LG, Andersson S, Sandström T, Larsson K; Obstructive Lung Disease in Northern Sweden Studies.

Respir Med. 2003 Feb;97(2):115-22.

PMID:
12587960
7.

Diagnosis of airway obstruction in the elderly: contribution of the SARA study.

Sorino C, Battaglia S, Scichilone N, Pedone C, Antonelli-Incalzi R, Sherrill D, Bellia V.

Int J Chron Obstruct Pulmon Dis. 2012;7:389-95. doi: 10.2147/COPD.S31630. Epub 2012 Jun 27.

8.

The prevalence of chronic obstructive pulmonary disease in Uppsala, Sweden--the Burden of Obstructive Lung Disease (BOLD) study: cross-sectional population-based study.

Danielsson P, Ólafsdóttir IS, Benediktsdóttir B, Gíslason T, Janson C.

Clin Respir J. 2012 Apr;6(2):120-7. doi: 10.1111/j.1752-699X.2011.00257.x. Epub 2011 Jul 6.

PMID:
21651748
9.

[Prevalence of chronic obstructive pulmonary disease and risk factors in smokers and ex-smokers].

Jaén Díaz JI, de Castro Mesa C, Gontán García-Salamanca MJ, López de Castro F.

Arch Bronconeumol. 2003 Dec;39(12):554-8. Spanish.

10.

Comparison of spirometry criteria for the diagnosis of COPD: results from the BOLD study.

Vollmer WM, Gíslason T, Burney P, Enright PL, Gulsvik A, Kocabas A, Buist AS.

Eur Respir J. 2009 Sep;34(3):588-97. doi: 10.1183/09031936.00164608. Epub 2009 May 21.

11.

COPD case finding by spirometry in high-risk customers of urban community pharmacies: a pilot study.

Castillo D, Guayta R, Giner J, Burgos F, Capdevila C, Soriano JB, Barau M, Casan P; FARMAEPOC group.

Respir Med. 2009 Jun;103(6):839-45. doi: 10.1016/j.rmed.2008.12.022. Epub 2009 Feb 5.

12.

Risk of over-diagnosis of COPD in asymptomatic elderly never-smokers.

Hardie JA, Buist AS, Vollmer WM, Ellingsen I, Bakke PS, Mørkve O.

Eur Respir J. 2002 Nov;20(5):1117-22.

13.

Characteristics of a population of COPD patients identified from a population-based study. Focus on previous diagnosis and never smokers.

Miravitlles M, Ferrer M, Pont A, Luis Viejo J, Fernando Masa J, Gabriel R, Jiménez-Ruiz CA, Villasante C, Fernández-Fau L, Sobradillo V.

Respir Med. 2005 Aug;99(8):985-95. Epub 2005 Mar 4.

14.

Comparison of the prevalence of chronic obstructive pulmonary disease diagnosed by lower limit of normal and fixed ratio criteria.

Hwang YI, Kim CH, Kang HR, Shin T, Park SM, Jang SH, Park YB, Kim CH, Kim DG, Lee MG, Hyun IG, Jung KS.

J Korean Med Sci. 2009 Aug;24(4):621-6. doi: 10.3346/jkms.2009.24.4.621. Epub 2009 Jul 29.

15.

Impact of bronchodilator use on the prevalence of COPD in population-based samples.

Pérez-Padilla R, Hallal PC, Vázquez-García JC, Muiño A, Máquez M, López MV, de Oca MM, Tálamo C, Valdivia G, Pertuzé J, Jardim J, Menezes AM; PLATINO group.

COPD. 2007 Jun;4(2):113-20.

PMID:
17530504
17.

Pulmonary function between 40 and 80 years of age.

Ostrowski S, Grzywa-Celińska A, Mieczkowska J, Rychlik M, Lachowska-Kotowska P, Lopatyński J.

J Physiol Pharmacol. 2005 Sep;56 Suppl 4:127-33.

18.

COPD 'diagnosis' based on spirometric reference equations.

Olofson J, Bake B, Tengelin MN, Houltz B.

Clin Respir J. 2008 Oct;2(4):214-9. doi: 10.1111/j.1752-699X.2008.00065.x.

PMID:
20298337
19.

Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms.

Lindberg A, Larsson LG, Rönmark E, Jonsson AC, Larsson K, Lundbäck B.

COPD. 2007 Mar;4(1):5-13.

PMID:
17364672
20.

Implications of reversibility testing on prevalence and risk factors for chronic obstructive pulmonary disease: a community study.

Johannessen A, Omenaas ER, Bakke PS, Gulsvik A.

Thorax. 2005 Oct;60(10):842-7. Epub 2005 Aug 5.

Items per page

Supplemental Content

Write to the Help Desk